Praxis Precision Medicines (PRAX) Securities - Tradable (2022 - 2025)
Historic Securities - Tradable for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $239.6 million.
- Praxis Precision Medicines' Securities - Tradable fell 119.16% to $239.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.6 million, marking a year-over-year decrease of 119.16%. This contributed to the annual value of $254.2 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, Praxis Precision Medicines' Securities - Tradable stood at $239.6 million, which was down 119.16% from $289.2 million recorded in Q2 2025.
- Praxis Precision Medicines' Securities - Tradable's 5-year high stood at $306.9 million during Q2 2024, with a 5-year trough of $5.0 million in Q1 2023.
- In the last 4 years, Praxis Precision Medicines' Securities - Tradable had a median value of $192.1 million in 2022 and averaged $176.8 million.
- In the last 5 years, Praxis Precision Medicines' Securities - Tradable plummeted by 9655.54% in 2023 and then surged by 238153.72% in 2024.
- Over the past 4 years, Praxis Precision Medicines' Securities - Tradable (Quarter) stood at $38.9 million in 2022, then plummeted by 87.19% to $5.0 million in 2023, then surged by 5000.46% to $254.2 million in 2024, then decreased by 5.71% to $239.6 million in 2025.
- Its last three reported values are $239.6 million in Q3 2025, $289.2 million for Q2 2025, and $306.5 million during Q1 2025.